Skip to content
Recall Observatory FDA recall evidence

Drug product

Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/320 mg/25 mg, (a) 30-count bottles (NDC 0093-7809-56) & 90-count bottles (NDC 0093-7809-98), RX Only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel, Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.

D-0310-2019

November 27, 2018

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 81646
Status
Ongoing
Classification
Class II
Quantity
31,079 bottles
Official record key
drug-enforcement:D-0310-2019

Official wording

Reason: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Code information: All lots within expiry. NDC 0093-7809-56 & NDC 0093-7809-98

Distribution pattern: USA Nationwide including Puerto Rico.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity, N-nitrosodimethylamine (NDEA
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations